Sebastian Kuchlin
Overview
Explore the profile of Sebastian Kuchlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuchlin S, Ihorst G, Heinrich S, Farassat N, Marquez Neila P, Hug M, et al.
Ophthalmology
. 2025 Jan;
PMID: 39827907
Purpose: To identify baseline clinical predictors of visual outcomes 6 months after acute optic neuritis using data from our completed clinical neuroprotection trial: Treatment of Optic Neuritis with Erythropoietin (TONE)....
2.
Nickel K, Tebartz van Elst L, Beringer M, Endres D, Runge K, Maier S, et al.
Front Neurosci
. 2024 Dec;
18:1501149.
PMID: 39654646
Background: Electroretinograms (ERG) are usually recorded with non-invasive corneal electrodes, requiring direct contact with the ocular surface. However, corneal electrode application is not tolerated by some individuals. The advent of...
3.
Nickel K, Heinrich S, Beringer M, Endres D, Runge K, Kuchlin S, et al.
Sci Rep
. 2024 Nov;
14(1):28160.
PMID: 39548175
Previous pattern electroretinogram studies indicate reduced retinal contrast gain in patients with a major depressive disorder (MDD) which may contribute to alterations in visual perception. In line, psychophysical investigations reported...
4.
Graf J, Weise M, Guthoff T, Balloff C, Gasis M, Link H, et al.
Front Immunol
. 2024 Sep;
15:1431394.
PMID: 39224585
Objectives: The pathophysiology of multiple sclerosis (MS) involves inflammatory neurodegeneration in the brainstem, cerebellum, and retina. The clinical relevance of oculomotor involvement in MS, however, remains uncertain. Methods: In this...
5.
Schuchardt F, Lutzen N, Kuchlin S, Reich M, Lagreze W, Mast H, et al.
Neuroradiology
. 2024 Apr;
66(7):1161-1176.
PMID: 38676750
Purpose: Intracranial hypertension (IH) frequently complicates cerebral venous thrombosis (CVT). Distinct neuroimaging findings are associated with IH, yet their discriminative power, reversibility and factors favoring normalization in prospective CVT patients...
6.
Kuchlin S, Ihorst G, Heinrich S, Marquez Neila P, Albrecht P, Hug M, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Apr;
11(3):e200223.
PMID: 38588480
Background And Objectives: Optic neuritis is the most common optic neuropathy in young adults and a frequent manifestation of multiple sclerosis. Its clinical course is pertinent to the design of...
7.
Kuchlin S, Ihorst G, Heinrich S, Marquez Neila P, Albrecht P, Hug M, et al.
JAMA Neurol
. 2024 Mar;
81(5):553-554.
PMID: 38526471
No abstract available.
8.
Schuchardt F, Krafft A, Miguel Telega L, Kuchlin S, Lagreze W, Demerath T, et al.
Clin Neuroradiol
. 2024 Jan;
34(2):391-401.
PMID: 38277058
Purpose: To quantify the effects of CSF pressure alterations on intracranial venous morphology and hemodynamics in idiopathic intracranial hypertension (IIH) and spontaneous intracranial hypotension (SIH) and assess reversibility when the...
9.
Kuchlin S, Ihorst G, Grotejohann B, Beisse F, Heinrich S, Albrecht P, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Apr;
10(4).
PMID: 37094997
Background And Objective: Erythropoietin (EPO) is a candidate neuroprotective drug. We assessed its long-term safety and efficacy as an adjunct to methylprednisolone in patients with optic neuritis and focused on...
10.
Farassat N, Bohringer D, Kuchlin S, Molnar F, Schwietering A, Seger D, et al.
BMJ Open
. 2023 Apr;
13(4):e068822.
PMID: 37080623
Introduction: Myopia is a major cause of degenerative eye disease and increases the risk of secondary visual impairment. Mitigating its progression therefore has great potential of clinically relevant benefit as...